Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar - Quiz - MDSpire

Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar

  • By

  • Sana Bentebbal

  • Ahmed Zaqout

  • Bakhita Meqbel

  • Ilham Bensmail

  • Abdullah Aldushain

  • Alberto de la Fuente

  • Remy Thomas

  • Adviti Naik

  • Hibah Shaath

  • Neyla S. Al-Akl

  • Abdi Adam

  • Houda Y. A. Moussa

  • Kyung C. Shin

  • Rowaida Z. Taha

  • Mohammed Abukhattab

  • Muna A. Al-Maslamani

  • Nehad M. Alajez

  • Abdelilah Arredouani

  • Yongsoo Park

  • Sara A. Abdulla

  • Omar M. A. El-Agnaf

  • Houari B. Abdesselem

  • Ali S. Omrani

  • Julie Decock

  • April 24, 2026

  • 0 min

Share

Original Source(s)

Longitudinal Analysis of Plasma Proteomic Alterations After BNT162b2 COVID-19 Booster Vaccination in Qatar

  • by Sana Bentebbal, Ahmed Zaqout, Bakhita Meqbel, Ilham Bensmail, Abdullah Aldushain, Alberto de la Fuente, Remy Thomas, Adviti Naik, Hibah Shaath, Neyla S. Al-Akl, Abdi Adam, Houda Y. A. Moussa, Kyung C. Shin, Rowaida Z. Taha, Mohammed Abukhattab, Muna A. Al-Maslamani, Nehad M. Alajez, Abdelilah Arredouani, Yongsoo Park, Sara A. Abdulla, Omar M. A. El-Agnaf, Houari B. Abdesselem, Ali S. Omrani, Julie Decock

  • April 24, 2026

Related Content

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update

Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients

Long COVID as a network disorder: a mechanism-anchored framework for biological stratification and therapeutic targeting